| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Jun 03, 2025 | Jun 05, 2025 | Megna Michael R CHIEF ACCOUNTING OFFICER | Sell | Kiniksa Pharmaceuticals International, Plc | KNSA | $28.75 | $437,316 | -31.85% |
| May 07, 2025 | May 09, 2025 | Megna Michael R CHIEF ACCOUNTING OFFICER | Sell | Kiniksa Pharmaceuticals International, Plc | KNSA | $26.69 | $470,998 | -35.16% |
| Mar 12, 2025 | Mar 14, 2025 | Megna Michael R CHIEF ACCOUNTING OFFICER | Sell | Kiniksa Pharmaceuticals International, Plc | KNSA | $22.45 | $203,195 | -25.44% |
| Nov 27, 2024 | Dec 02, 2024 | Megna Michael R CHIEF ACCOUNTING OFFICER | Sell | Kiniksa Pharmaceuticals International, Plc | KNSA | $22.45 | $194,103 | -24.58% |
| Feb 28, 2024 | Mar 01, 2024 | Megna Michael R CHIEF ACCOUNTING OFFICER | Sell | Kiniksa Pharmaceuticals, Ltd. | KNSA | $21.57 | $318,881 | -45.67% |
| Jan 02, 2024 | Jan 04, 2024 | Megna Michael R CHIEF ACCOUNTING OFFICER | Sell | Kiniksa Pharmaceuticals, Ltd. | KNSA | $19.17 | $319,564 | -49.50% |
| Dec 19, 2023 | Dec 21, 2023 | Megna Michael R CHIEF ACCOUNTING OFFICER | Sell | Kiniksa Pharmaceuticals, Ltd. | KNSA | $19.13 | $178,215 | -35.39% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.